1 / 8

U.S. Amniotic Membrane Market

The U.S. amniotic membrane market accounted for $189 million in 2012 and is expected to reach $722 million by 2022, registering a CAGR of 13.6% from 2017 to 2022.

Niranjanpetkar
Download Presentation

U.S. Amniotic Membrane Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Amniotic membrane Market Size is set to Grow at a Remarkable Pace in the Coming Years.

  2. U.S. Amniotic Membrane Market Overview: - The U.S. amniotic membrane market accounted for $189 million in 2012 and is expected to reach $722 million by 2022, registering a CAGR of 13.6% from 2017 to 2022. Amniotic membrane refers to the innermost layer of the placenta, which comprises of a thick basement membrane and an avascular stromal matrix. This membrane can be used as a graft as well as for a dressing to promote wound and ocular surface reconstruction so as to facilitate healing. Access Full Report:- http://bit.ly/2PArpqlThe advanced wound care industry being technology-driven has facilitated the development of superior quality amniotic membranes. Apart from conventional applications such as wound management, amniotic membrane are also used in the field of ophthalmology and orthopedics. Moreover, amniotic membranes are being used in oncology interventions. The U.S. amniotic membrane market is highly competitive in nature, owing to the presence of numerous companies offering diverse amniotic membranes.Based on product, the U.S. amniotic membrane market is bifurcated into cryopreserved amniotic membrane and lyophilized amniotic membrane. Furthermore, by application, the market is categorized into surgical wound, ophthalmology, and other applications. Based on region, it is analyzed across the west, southwest, mid-west, the south, New England, and middle-Atlantic regions of the U.S.

  3. U.S. Amniotic Membrane Market Overview: - The U.S. amniotic membrane market is dynamic in nature and has witnessed an array of different developments. Some of the key developments in the U. S. amniotic membrane industry include product approvals & launches, agreements, collaborations, and acquisitions. Get Sample Report: - http://bit.ly/2Pvv3BU For instance, in July 2014, a U.S.-based company, Amniox Medical, Inc. received American Podiatric Medical Association (APMA) Seal of Approval for its NEOX Wound Matrix and CLARIX Regenerative Matrix product lines. Moreover, in June 2017, Amniox Medical, Inc. entered into a strategic agreement with Intalere to provide its human tissue allograft technology that is composed of both umbilical cord and amniotic membrane for wound healing and soft tissue repair. Similarly, in January 2015, a U.S.-based medical device company, Derma Sciences Inc. expanded access of its Amniotic Tissue product line with new Premier, Inc. With the help of this strategy, amniotic allografts, AMNIOEXCEL and AMNIOMATRIX, derived from placental tissues, are added to the Premier, Inc.’s regenerative skin grafting contract portfolio.

  4. U.S. Amniotic Membrane Market Overview: - Furthermore, some of the key product developments in the U.S. amniotic membrane market are mentioned below. For instance, in September 2017, a U.S.-based company, Amnio Technology, LLC launched the PalinGen InovFlo, expanding its product line globally. PalinGen lnovFlo is a minimally manipulated liquid allograft derived from human amniotic fluid, which is intended for homologous use for supplementing tissue for protection, cushioning, and lubrication. Similarly, in April 2014, a U.S.-based company, Alliqua Biomedical, Inc. Alliqua launched its Biovance human amniotic membrane allograft product at Booth #1208 at the Spring 2014 Symposium on Advanced Wound Care held at the Gaylord Palms Hotel and Convention Center in Orlando, Florida. This product, licensed from Celgene, was developed to assist wound care specialists, physicians, nurses, as well as vascular, plastic, and general surgeons in the treatment of a wide variety of complex, acute, chronic, recalcitrant, full, and partial thickness wound types.

  5. Market Dynamics: - Drivers: - Surge in geriatric population - Increase in technological advancements and rise in amniotic membrane transplantations - Surge in awareness due to reduced healthcare costs Restraint: - Dearth of skilled professionals Market Players:The major players operating in the U.S. amniotic membrane market include Fziomed, Inc., Skye Biologics Inc., IOP Ophthalmics, Amniox Medical, Inc., Amnio Technology LLC, Applied Biologics LLC, Alliqua Biomedical, Inc., Human Regenerative Technologies, LLC, Derma Sciences Inc., and Mimedx Group, Inc.

  6. Key Take A Ways: -

  7. Market Landscape: - By Product: - Cryopreserved Amniotic Membrane - Lyophilized Amniotic Membrane By Application: - Surgical Wound - Ophthalmology - Others By Region: - The West - Southwest - The Midwest - The South - New England - The Middle Atlantic

  8. For More Details: - Visit Us at: - https://www.progressivemarkets.com/industry-research/united-states-amniotic-membrane-market Contact us: - Mr. ShriramDighe 4th Floor, Unit 12, Marisoft III,  West Wing, Marigold IT Park,  KalyaniNagar, Pune, Maharashtra 411014,  India: +91 20 66346040  Toll Free: + 1-888-906-9222  help@progressivemarkets.com

More Related